Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells-Reference-Cited by-同舟云学术

Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells

Published:2018-03-17 Issue:5 Volume:265 Page:1199-1209
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Ceronie Bryan,Jacobs Benjamin M.,Baker David^ORCID,Dubuisson Nicolas,Mao Zhifeng,Ammoscato Francesca,Lock Helen,Longhurst Hilary J.,Giovannoni Gavin,Schmierer Klaus

Funder

Multiple Sclerosis Society

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/article/10.1007/s00415-018-8830-y/fulltext.html

Reference39 articles.

1. Legroux L, Arbour N (2015) Multiple sclerosis and T lymphocytes: an entangled story. J Neuroimmune Pharmacol 10:528–546

2. Sefia E, Pryce G, Meier UC et al (2017) Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis. Mult Scler Relat Disord 14:46–50

3. van Oosten BW, Lai M, Hodgkinson S et al (1997) Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 49:351–357

4. Baker D, Marta M, Pryce G et al (2017) Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis. EBioMedicine 16:41–50

5. Cohen JA, Coles AJ, Arnold DL et al (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 380:1819–1828

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cladribine tablets in Relapsing-Remitting Multiple Sclerosis preferentially target B-cells;2024-03-29

2. Targeting Epstein–Barr virus in multiple sclerosis: when and how?;Current Opinion in Neurology;2024-03-21

3. How to and should we target EBV in MS?;Expert Review of Clinical Immunology;2024-03-15

4. Magnetic Resonance Imaging Evidence Supporting the Efficacy of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis;CNS Drugs;2024-03-15

5. Metabolic imbalance driving immune cell phenotype switching in autoimmune disorders: Tipping the balance of T‐ and B‐cell interactions;Clinical and Translational Medicine;2024-03